This publication list includes only the more recent review articles and is updated every day via PubMed. A list including the research articles is also available. IDIGH principal investigators are in bold.

CTB

  1. Zuberbier, T., Abdul Latiff, A., Aggelidis, X., Augustin, M., Balan, R.-G., Bangert, C., Beck, L., Bieber, T., Bernstein, J. A., Bertolin Colilla, M., Berardi, A., Bedbrook, A., Bindslev-Jensen, C., Bousquet, J., de Bruin-Weller, M., Bruscky, D., Buyuktiryaki, B., Canonica, G. W., Castro, C., Chanturidze, N., Chong-Neto, H. J., Chu, C.-Y., Chularojanamontri, L., Cork, M., Criado, R. F. J., Barredo, L. C., Custovic, A., Darsow, U., Emurlai, A., de Pablo, A., Del Giacco, S., Girolomoni, G., Deleva Jovanova, T., Deleuran, M., Douladiris, N., Duarte, B., Dubakiene, R., Eller, E., Engel-Yeger, B., Ensina, L. F., Filho, N. R., Flohr, C., Fomina, D., Francuzik, W., Galimberti, M. L., Giménez-Arnau, A. M., Godse, K., Mortz, C. G., Gotua, M., Hide, M., Hoetzenecker, W., Hunzelmann, N., Irvine, A., Jack, C., Kanavarou, I., Katoh, N., Kinaciyan, T., Kocatürk, E., Kulthanan, K., Lapeere, H., Lau, S., Machado Forti Nastri, M., Makris, M., Mansour, E., Marsland, A., Morelo Rocha Felix, M., Moschione Castro, A. P., Nettis, E., Nicolas, J. F., Nosbaum, A., Odemyr, M., Papapostolou, N., Parisi, C. A. S., Paudel, S., Peter, J., Pokharel, P., Puig, L., Quint, T., Ramon, G. D., Regateiro, F., Ricci, G., Rosario, C., Sackesen, C., Schmid-Grendelmeier, P., Serra-Baldrich, E., Siemens, K., Smith, C., Staubach, P., Stevanovic, K., Su-Kücük, Ö., Sussman, G., Tavecchio, S., Teovska Mitrevska, N., Thaci, D., Toubi, E., Traidl-Hoffmann, C., Treudler, R., Vadasz, Z., van Hofman, I., Ventura, M. T., Wang, Z., Werfel, T., Wollenberg, A., Yang, A., Weng Yew, Y., Zhao, Z., Zwiener, R. & Worm, M. (2023). A concept for integrated care pathways for atopic dermatitis-A GA2 LEN ADCARE initiative. Clinical and translational allergy, vol. 13, p. e12299.
  2. Conte, S., Aldien, A. S., Jetté, S., LeBeau, J., Alli, S., Netchiporouk, E., Lagacé, F., Lefrançois, P., Iannattone, L. & Litvinov, I. V. (2023). Skin Cancer Prevention across the G7, Australia and New Zealand: A Review of Legislation and Guidelines. Current oncology (Toronto, Ont.), vol. 30, p. 6019-6040.
  3. Ghahari, N., Telittchenko, R., Loucif, H., Isnard, S., Routy, J.-P., Olagnier, D. & van Grevenynghe, J. (2023). Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1. International journal of molecular sciences, vol. 24.
  4. Lagacé, F., D'Aguanno, K., Prosty, C., Laverde-Saad, A., Cattelan, L., Ouchene, L., Oliel, S., Genest, G., Doiron, P., Richer, V., Jfri, A., O'Brien, E., Lefrançois, P., Powell, M., Moreau, L., Litvinov, I. V., Muntyanu, A. & Netchiporouk, E. (2023). The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications. Journal of cutaneous medicine and surgery, p. 12034754231177582.
  5. Alvarez, F. & Piccirillo, C. A. (2023). The functional adaptation of effector Foxp3+ regulatory T cells to pulmonary inflammation. European journal of immunology, p. e2250273.
  6. Giralt, S., Jolles, S., Kerre, T., Lazarus, H. M., Mustafa, S. S., Papanicolaou, G. A., Ria, R., Vinh, D. C. & Wingard, J. R. (2023). Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma. Clinical lymphoma, myeloma & leukemia, vol. 23, p. 719-732.
  7. Dubé, J.-Y. & Behr, M. A. (2023). A nod to the bond between NOD2 and mycobacteria. PLoS pathogens, vol. 19, p. e1011389.
  8. Koger-Pease, C., Perera, D. J. & Ndao, M. (2023). Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections. Pharmaceuticals (Basel, Switzerland), vol. 16.
  9. Vinh, D. C. (2023). Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases. Pathogens (Basel, Switzerland), vol. 12.
  10. Arcuri, D., Ramchatesingh, B., Lagacé, F., Iannattone, L., Netchiporouk, E., Lefrançois, P. & Litvinov, I. V. (2023). Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review. International journal of molecular sciences, vol. 24.
  11. Olbrich, P. & Vinh, D. C. (2023). Inborn Errors of Immunity Causing Pediatric Susceptibility to Fungal Diseases. Journal of fungi (Basel, Switzerland), vol. 9.
  12. Muntyanu, A., Gabrielli, S., Donovan, J., Gooderham, M., Guenther, L., Hanna, S., Lynde, C., Prajapati, V. H., Wiseman, M. & Netchiporouk, E. (2023). The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity. Journal of the European Academy of Dermatology and Venereology : JEADV.
  13. Adam, D. N., Gooderham, M. J., Beecker, J. R., Hong, C. H., Jack, C. S., Jain, V., Lansang, P., Lynde, C. W., Papp, K. A., Prajapati, V. H., Turchin, I. & Yeung, J. (2023). Expert consensus on the systemic treatment of atopic dermatitis in special populations. Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 37, p. 1135-1148.
  14. Le Mauff, F. & Sheppard, D. C. (2023). Understanding Aspergillus fumigatus galactosaminogalactan biosynthesis: A few questions remain. Cell surface (Amsterdam, Netherlands), vol. 9, p. 100095.
  15. Brosseau, N. E., Vallée, I., Mayer-Scholl, A., Ndao, M. & Karadjian, G. (2023). Aptamer-Based Technologies for Parasite Detection. Sensors (Basel, Switzerland), vol. 23.
  16. Shah, N., Mustafa, S. S. & Vinh, D. C. (2023). Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology. Critical reviews in oncology/hematology, vol. 181, p. 103896.
  17. van Griensven, J., Diro, E. & Yansouni, C. P. (2023). Hidden sources of bias in diagnostic studies: the example of visceral leishmaniasis in east Africa. The Lancet. Infectious diseases, vol. 23, p. e108-e114.
  18. Ortiz-Brizuela, E., Menzies, D. & Behr, M. A. (2022). Testing and Treating Mycobacterium tuberculosis Infection. The Medical clinics of North America, vol. 106, p. 929-947.
  19. Motamedi, M., Ferrara, G., Yacyshyn, E., Osman, M., Abril, A., Rahman, S., Netchiporouk, E. & Gniadecki, R. (2023). Skin disorders and interstitial lung disease: Part I-Screening, diagnosis, and therapeutic principles. Journal of the American Academy of Dermatology, vol. 88, p. 751-764.
  20. Ouchene, L., Muntyanu, A., Assayag, D., Veilleux, È., Abril, A., Ferrara, G., Yacyshyn, E., Pineau, C. A., O'Brien, E., Baron, M., Osman, M., Gniadecki, R. & Netchiporouk, E. (2023). Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease association. Journal of the American Academy of Dermatology, vol. 88, p. 767-782.
  21. Lopez-Olivo, M. A., Valerio, V., Karpes Matusevich, A. R., Brizio, M., Kwok, M., Geng, Y., Suarez-Almazor, M. E. & Colmegna, I. (2022). Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis. Vaccines, vol. 10.
  22. Mboumba Bouassa, R.-S., Sebastiani, G., Di Marzo, V., Jenabian, M.-A. & Costiniuk, C. T. (2022). Cannabinoids and Chronic Liver Diseases. International journal of molecular sciences, vol. 23.
  23. Garcia-Basteiro, A. L., White, R. G., Tait, D., Schmidt, A. C., Rangaka, M. X., Quaife, M., Nemes, E., Mogg, R., Hill, P. C., Harris, R. C., Hanekom, W. A., Frick, M., Fiore-Gartland, A., Evans, T., Dagnew, A. F., Churchyard, G., Cobelens, F., Behr, M. A. & Hatherill, M. (2022). End-point definition and trial design to advance tuberculosis vaccine development. European respiratory review : an official journal of the European Respiratory Society, vol. 31.
  24. Merati, N., Sivachandran, S., Jfri, A., Ben-Shoshan, M., Vinh, D. C., Popradi, G. & Litvinov, I. V. (2022). Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?. Skin therapy letter, vol. 27, p. 1-5.
  25. Ahmed, D. S., Isnard, S., Berini, C., Lin, J., Routy, J.-P. & Royston, L. (2022). Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity. Frontiers in immunology, vol. 13, p. 820350.

 

CORE

  1. Thompson, W. & McDonald, E. G. (2023). Polypharmacy and Deprescribing in Older Adults. Annual review of medicine.
  2. Reid, M., Agbassi, Y. J. P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D., Churchyard, G., Cox, H., Denkinger, C. M., Ditiu, L., Dowdy, D., Dybul, M., Fauci, A., Fedaku, E., Gidado, M., Harrington, M., Hauser, J., Heitkamp, P., Herbert, N., Herna Sari, A., Hopewell, P., Kendall, E., Khan, A., Kim, A., Koek, I., Kondratyuk, S., Krishnan, N., Ku, C.-C., Lessem, E., McConnell, E. V., Nahid, P., Oliver, M., Pai, M., Raviglione, M., Ryckman, T., Schäferhoff, M., Silva, S., Small, P., Stallworthy, G., Temesgen, Z., van Weezenbeek, K., Vassall, A., Velásquez, G. E., Venkatesan, N., Yamey, G., Zimmerman, A., Jamison, D., Swaminathan, S. & Goosby, E. (2023). Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet (London, England).
  3. Roy, A.-S., Hagh-Doust, H., Abdul Azim, A., Caceres, J., Denholm, J. T., Dong, M. Q. D., King, M., Yen, C. F., Lee, T. C. & McDonald, E. G. (2023). Multidisciplinary Teams for the Management of Infective Endocarditis: A Systematic Review and Meta-analysis. Open forum infectious diseases, vol. 10, p. ofad444.
  4. Milic, J., Calza, S., Cantergiani, S., Albertini, M., Gallerani, A., Menozzi, M., Barp, N., Todisco, V., Renzetti, S., Motta, F., Mussini, C., Sebastiani, G., Raggi, P. & Guaraldi, G. (2023). Sarcopenic Obesity Phenotypes in Patients With HIV: Implications for Cardiovascular Prevention and Rehabilitation. The Canadian journal of cardiology.
  5. Faust, L., Naidoo, P., Caceres-Cardenas, G., Ugarte-Gil, C., Muyoyeta, M., Kerkhoff, A. D., Nagarajan, K., Satyanarayana, S., Rakotosamimanana, N., Grandjean Lapierre, S., Adejumo, O. A., Kuye, J., Oga-Omenka, C., Pai, M. & Subbaraman, R. (2023). Improving measurement of tuberculosis care cascades to enhance people-centred care. The Lancet. Infectious diseases.
  6. Santos, M. J. L., Merrill, K. A., Ben-Shoshan, M., Gerdts, J. D., Giesbrecht, D., Lavine, E., Prentice, S., Upton, J. & Protudjer, J. L. P. (2023). Food Allergy Education and Management in Early Learning and Childcare Centres: A Scoping Review on Current Practices and Gaps. Children (Basel, Switzerland), vol. 10.
  7. Greenhawt, M., Dribin, T. E., Abrams, E. M., Shaker, M., Chu, D. K., Golden, D. B., Akin, C., Anagnostou, A., ALMuhizi, F., Alqurashi, W., Arkwright, P., Baldwin, J. L., Banerji, A., Bégin, P., Ben-Shoshan, M., Bernstein, J., Bingeman, T. A., Bindslev-Jensen, C., Blumenthal, K., Byrne, A., Cahil, J., Cameron, S., Campbell, D., Campbell, R., Cavender, M., Chan, E. S., Chinthrajah, S., Comberiatti, P., Eastman, J. J., Ellis, A. K., Fleischer, D. M., Fox, A., Frischmeyer-Guerrerio, P. A., Gagnon, R., Garvey, L. H., Grayson, M. H., Clarisse Isabwe, G. A., Hartog, N., Hendron, D., Horner, C. C., O'B Hourihane, J., Iglesia, E., Kan, M., Kaplan, B., Katelaris, C. H., Kim, H., Kelso, J. M., Kahn, D. A., Lang, D., Ledford, D., Levin, M., Lieberman, J. A., Loh, R., Mack, D. P., Mazer, B., Mody, K., Mosnaim, G., Munblit, D., Mustafa, S. S., Nanda, A., Nathan, R., Oppenheimer, J., Otani, I. M., Park, M., Pawankar, R., Perrett, K. P., Peter, J., Phillips, E. J., Picard, M., Pitlick, M., Ramsey, A., Rasmussen, T. H., Rathkopf, M. M., Reddy, H., Robertson, K., Rodriguez Del Rio, P., Sample, S., Sheshradi, A., Shiek, J., Sindher, S. B., Spergel, J. M., Stone, C. A., Stukus, D., Tang, M. L., Tracy, J. M., Turner, P. J., Vander Leek, T. K., Wallace, D. V., Wang, J., Wasserman, S., Weldon, D., Wolfson, A. R., Worm, M. & Yacoub, M.-R. (2023). Updated Guidance Regarding The Risk ofAllergic Reactions to COVID-19 Vaccines and Recommended Evaluation and Management: A GRADE Assessment, and International Consensus Approach. The Journal of allergy and clinical immunology, vol. 152, p. 309-325.
  8. Cinque, F., Cespiati, A., Lombardi, R., Guaraldi, G. & Sebastiani, G. (2023). Nutritional and Lifestyle Therapy for NAFLD in People with HIV. Nutrients, vol. 15.
  9. Elgretli, W., Chen, T., Kronfli, N. & Sebastiani, G. (2023). Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines, vol. 11.
  10. Batac, A. L. R., Merrill, K. A., Askin, N., Golding, M. A., Abrams, E. M., Bégin, P., Ben-Shoshan, M., Ladouceur, E., Roos, L. E., Protudjer, V. & Protudjer, J. L. P. (2023). Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review. The journal of allergy and clinical immunology. Global, vol. 2, p. 100079.
  11. Akhtar, H., Chaudhry, S. H., Bortolussi-Courval, É., Hanula, R., Akhtar, A., Nauche, B. & McDonald, E. G. (2023). Diagnostic yield of CT head in delirium and altered mental status-A systematic review and meta-analysis. Journal of the American Geriatrics Society, vol. 71, p. 946-958.
  12. Liu, J. L., Woo, J. M. P., Parks, C. G., Costenbader, K. H., Jacobsen, S. & Bernatsky, S. (2022). Systemic Lupus Erythematosus Risk: The Role of Environmental Factors. Rheumatic diseases clinics of North America, vol. 48, p. 827-843.
  13. Copaescu, A. M., Ben-Shoshan, M. & Trubiano, J. A. (2022). Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions. Frontiers in medicine, vol. 9, p. 923991.
  14. McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval, É., Albuquerque, A. M., Tong, S. Y. C., Hamilton, F. & Lee, T. C. (2023). Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, p. 165-170.
  15. Mboumba Bouassa, R.-S., Sebastiani, G., Di Marzo, V., Jenabian, M.-A. & Costiniuk, C. T. (2022). Cannabinoids and Chronic Liver Diseases. International journal of molecular sciences, vol. 23.
  16. Briller, J. E., Aggarwal, N. R., Davis, M. B., Hameed, A. B., Malhamé, I., Mahmoud, Z., McDonald, E. G., Moraes de Oliveira, G., Quesada, O., Scott, N. S., Sharma, J. & American College of Cardiology Cardiovascular Disease in Women Committee (2022). Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections. JACC. Advances, vol. 1, p. 100057.
  17. Albuquerque, A. M., Eckert, I., Tramujas, L., Butler-Laporte, G., McDonald, E. G., Brophy, J. M. & Lee, T. C. (2023). Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, p. 13-21.
  18. Zimmer, A. J., Ugarte-Gil, C., Pathri, R., Dewan, P., Jaganath, D., Cattamanchi, A., Pai, M. & Grandjean Lapierre, S. (2022). Making cough count in tuberculosis care. Communications medicine, vol. 2, p. 83.
  19. Ensina, L. F., Brandão, L. S., Neto, H. C. & Ben-Shoshan, M. (2022). Urticaria and angioedema in children and adolescents: diagnostic challenge. Allergologia et immunopathologia, vol. 50, p. 17-29.
  20. Vaugon, E., Mircescu, A., Caya, C., Yao, M., Gore, G., Dendukuri, N. & Papenburg, J. (2022). Diagnostic accuracy of rapid one-step PCR assays for detection of herpes simplex virus-1 and -2 in cerebrospinal fluid: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, p. 1547-1557.
  21. Prosty, C., Copaescu, A. M., Gabrielli, S., Mule, P. & Ben-Shoshan, M. (2022). Pediatric Drug Allergy. Immunology and allergy clinics of North America, vol. 42, p. 433-452.
  22. Merati, N., Sivachandran, S., Jfri, A., Ben-Shoshan, M., Vinh, D. C., Popradi, G. & Litvinov, I. V. (2022). Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?. Skin therapy letter, vol. 27, p. 1-5.
  23. McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
  24. Lazarus, J. V., Safreed-Harmon, K., Kamarulzaman, A., Anderson, J., Leite, R. B., Behrens, G., Bekker, L.-G., Bhagani, S., Brown, D., Brown, G., Buchbinder, S., Caceres, C., Cahn, P. E., Carrieri, P., Caswell, G., Cooke, G. S., Monforte, A. D., Dedes, N., Del Amo, J., Elliott, R., El-Sadr, W. M., Fuster-Ruiz de Apodaca, M. J., Guaraldi, G., Hallett, T., Harding, R., Hellard, M., Jaffar, S., Kall, M., Klein, M., Lewin, S. R., Mayer, K., Pérez-Molina, J. A., Moraa, D., Naniche, D., Nash, D., Noori, T., Pozniak, A., Rajasuriar, R., Reiss, P., Rizk, N., Rockstroh, J., Romero, D., Sabin, C., Serwadda, D. & Waters, L. (2021). Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nature communications, vol. 12, p. 4450.
  25. Belmesk, L., Muntyanu, A., Cantin, E., AlHalees, Z., Jack, C. S., Le, M., Sasseville, D., Iannattone, L., Ben-Shoshan, M., Litvinov, I. V. & Netchiporouk, E. (2022). Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis. Journal of cutaneous medicine and surgery, vol. 26, p. 33-49.

 

Clinical

  1. Del Corpo, O., Senécal, J., Hsu, J. M., Lawandi, A. & Lee, T. C. (2023). Rapid phenotypic testing for detection of carbapenemase- or extended spectrum ß-lactamase-producing Enterobacterales directly from blood cultures: A systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  2. Graff, L. A., Geist, R., Kuenzig, M. E., Benchimol, E. I., Kaplan, G. G., Windsor, J. W., Bitton, A., Coward, S., Jones, J. L., Lee, K., Murthy, S. K., Peña-Sánchez, J.-N., Targownik, L. E., Jannati, N., Jones May, T., Akhtar Sheekha, T., Davis, T., Weinstein, J., Dahlwi, G., Im, J. H. B., Amankwah Osei, J., Rohatinsky, N., Ghandeharian, S., Goddard, Q., Gorospe, J., Gertsman, S., Louis, M., Wagner, R., Brass, C., Sanderson, R. & Bernstein, C. N. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S64-S75.
  3. Roy, A.-S., Hagh-Doust, H., Abdul Azim, A., Caceres, J., Denholm, J. T., Dong, M. Q. D., King, M., Yen, C. F., Lee, T. C. & McDonald, E. G. (2023). Multidisciplinary Teams for the Management of Infective Endocarditis: A Systematic Review and Meta-analysis. Open forum infectious diseases, vol. 10, p. ofad444.
  4. Shaffer, S. R., Kuenzig, M. E., Windsor, J. W., Bitton, A., Jones, J. L., Lee, K., Murthy, S. K., Targownik, L. E., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Tandon, P., St-Pierre, J., Natt, N., Davis, T., Weinstein, J., Im, J. H. B., Benchimol, E. I., Kaplan, G. G., Goddard, Q., Gorospe, J., Bergevin, M., Silver, K., Bowles, D., Stewart, M., Pearlstein, M., Dawson, E. H. & Bernstein, C. N. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-IBD in Seniors. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S45-S54.
  5. Murthy, S. K., Kuenzig, M. E., Windsor, J. W., Matthews, P., Tandon, P., Benchimol, E. I., Bernstein, C. N., Bitton, A., Coward, S., Jones, J. L., Kaplan, G. G., Lee, K., Targownik, L. E., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Meka, S., Chis, R. S., Gupta, S., Cheah, E., Davis, T., Weinstein, J., Im, J. H. B., Goddard, Q., Gorospe, J., Loschiavo, J., McQuaid, K., D'Addario, J., Silver, K., Oppenheim, R. & Singh, H. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S83-S96.
  6. Murthy, S. K., Weizman, A. V., Kuenzig, M. E., Windsor, J. W., Kaplan, G. G., Benchimol, E. I., Bernstein, C. N., Bitton, A., Coward, S., Jones, J. L., Lee, K., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Sabrie, N., Gupta, S., Brar, G., Khan, R., Im, J. H. B., Davis, T., Weinstein, J., St-Pierre, J., Chis, R., Meka, S., Cheah, E., Goddard, Q., Gorospe, J., Kerr, J., Beaudion, K. D., Patel, A., Russo, S., Blyth, J., Blyth, S., Charron-Bishop, D. & Targownik, L. E. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S97-S110.
  7. Windsor, J. W., Kuenzig, M. E., Murthy, S. K., Bitton, A., Bernstein, C. N., Jones, J. L., Lee, K., Targownik, L. E., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Im, J. H. B., Davis, T., Weinstein, J., Goddard, Q., Benchimol, E. I. & Kaplan, G. G. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S1-S8.
  8. Targownik, L. E., Bollegala, N., Huang, V. H., Windsor, J. W., Kuenzig, M. E., Benchimol, E. I., Kaplan, G. G., Murthy, S. K., Bitton, A., Bernstein, C. N., Jones, J. L., Lee, K., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Davis, T., Weinstein, J., Im, J. H. B., Jannati, N., Khan, R., Matthews, P., Jones May, T., Tabatabavakili, S., Jogendran, R., Hazan, E., Browne, M., Meka, S., Vukovic, S., Jogendran, M., Hu, M., Osei, J. A., Wang, G. Y., Sheekha, T. A., Dahlwi, G., Goddard, Q., Gorospe, J., Nisbett, C., Gertsman, S., Sousa, J., Morganstein, T., Stocks, T., Weber, A. & Seow, C. H. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S55-S63.
  9. El-Matary, W., Carroll, M. W., Deslandres, C., Griffiths, A. M., Kuenzig, M. E., Mack, D. R., Wine, E., Weinstein, J., Geist, R., Davis, T., Chan, J., Khan, R., Matthews, P., Kaplan, G. G., Windsor, J. W., Bernstein, C. N., Bitton, A., Coward, S., Jones, J. L., Lee, K., Murthy, S. K., Targownik, L. E., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Im, J. H. B., Goddard, Q., Gorospe, J., Verdugo, J., Morin, S. A., Morganstein, T., Banning, L. & Benchimol, E. I. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-Children and Adolescents with IBD. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S35-S44.
  10. Mathias, H., Rohatinsky, N., Murthy, S. K., Novak, K., Kuenzig, M. E., Nguyen, G. C., Fowler, S., Benchimol, E. I., Coward, S., Kaplan, G. G., Windsor, J. W., Bernstein, C. N., Targownik, L. E., Peña-Sánchez, J.-N., Lee, K., Ghandeharian, S., Jannati, N., Weinstein, J., Khan, R., Im, J. H. B., Matthews, P., Davis, T., Goddard, Q., Gorospe, J., Latos, K., Louis, M., Balche, N., Dobranowski, P., Patel, A., Porter, L. J., Porter, R. M., Bitton, A. & Jones, J. L. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S111-S121.
  11. Kuenzig, M. E., Im, J. H. B., Coward, S., Windsor, J. W., Kaplan, G. G., Murthy, S. K., Benchimol, E. I., Bernstein, C. N., Bitton, A., Jones, J. L., Lee, K., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Jones May, T., Tabatabavakili, S., Jogendran, R., Weinstein, J., Khan, R., Hazan, E., Browne, M., Davis, T., Goddard, Q., Gorospe, J., Latos, K., Mason, K., Kerr, J., Balche, N., Sklar, A. & Targownik, L. E. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S16-S22.
  12. Kaplan, G. G., Kuenzig, M. E., Windsor, J. W., Bernstein, C. N., Bitton, A., Coward, S., Jones, J. L., Lee, K., Murthy, S. K., Targownik, L. E., Peña-Sánchez, J.-N., Ghandeharian, S., Rohatinsky, N., Weinstein, J., Jones May, T., Browne, M., Jannati, N., Tabatabavakili, S., Im, J. H. B., Meka, S., Vukovic, S., Davis, T., Goddard, Q., Gorospe, J., Stocks, T., Caplan, L., Kanaan, N., Stuart, D., Ramsay, T., Robinson, K. J., Charron-Bishop, D. & Benchimol, E. I. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S76-S82.
  13. Kuenzig, M. E., Coward, S., Targownik, L. E., Murthy, S. K., Benchimol, E. I., Windsor, J. W., Bernstein, C. N., Bitton, A., Jones, J. L., Lee, K., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Im, J. H. B., Jogendran, R., Meka, S., Weinstein, J., Jones May, T., Jogendran, M., Tabatabavakili, S., Hazan, E., Hu, M., Osei, J. A., Khan, R., Wang, G., Browne, M., Davis, T., Goddard, Q., Gorospe, J., Latos, K., Mason, K., Kerr, J., Balche, N., Sklar, A. & Kaplan, G. G. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S23-S34.
  14. Coward, S., Benchimol, E. I., Kuenzig, M. E., Windsor, J. W., Bernstein, C. N., Bitton, A., Jones, J. L., Lee, K., Murthy, S. K., Targownik, L. E., Peña-Sánchez, J.-N., Rohatinsky, N., Ghandeharian, S., Im, J. H. B., Davis, T., Weinstein, J., Goddard, Q., Bennett, J., Caplan, L., Bergevin, M., Yang, X. Y., Mason, K., Sanderson, R., Brass, C. & Kaplan, G. G. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD. Journal of the Canadian Association of Gastroenterology, vol. 6, p. S9-S15.
  15. Alphonsus, L., De Silva, T. A., Ma, C., MacDonald, J. K., Hanzel, J., Beaton, M., Bessissow, T., Kayal, M., Sedano, R., Singh, S. & Jairath, V. (2023). Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis. Alimentary pharmacology & therapeutics, vol. 58, p. 268-282.
  16. Wetwittayakhlang, P., Tselekouni, P., Al-Jabri, R., Bessissow, T. & Lakatos, P. L. (2023). The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer. Journal of clinical medicine, vol. 12.
  17. Pilia, E., Belletti, A., Fresilli, S., Lee, T. C., Zangrillo, A., Finco, G., Landoni, G. & full anticoagulation (2023). The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies. Lung, vol. 201, p. 135-147.
  18. Kehler, D. S., Milic, J., Guaraldi, G., Fulop, T. & Falutz, J. (2022). Frailty in older people living with HIV: current status and clinical management. BMC geriatrics, vol. 22, p. 919.
  19. Ouchene, L., Muntyanu, A., Assayag, D., Veilleux, È., Abril, A., Ferrara, G., Yacyshyn, E., Pineau, C. A., O'Brien, E., Baron, M., Osman, M., Gniadecki, R. & Netchiporouk, E. (2023). Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease association. Journal of the American Academy of Dermatology, vol. 88, p. 767-782.
  20. McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval, É., Albuquerque, A. M., Tong, S. Y. C., Hamilton, F. & Lee, T. C. (2023). Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, p. 165-170.
  21. Hahn, G. D., Golovics, P. A., Wetwittayakhlang, P., Santa Maria, D. M., Britto, U., Wild, G. E., Afif, W., Bitton, A., Bessissow, T. & Lakatos, P. L. (2022). Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Journal of clinical medicine, vol. 11.
  22. Albuquerque, A. M., Eckert, I., Tramujas, L., Butler-Laporte, G., McDonald, E. G., Brophy, J. M. & Lee, T. C. (2023). Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, p. 13-21.
  23. Tornai, D., Ven, P. L., Lakatos, P. L. & Papp, M. (2022). Serological biomarkers for management of primary sclerosing cholangitis. World journal of gastroenterology, vol. 28, p. 2291-2301.
  24. Wetwittayakhlang, P., Al Khoury, A., Hahn, G. D. & Lakatos, P. L. (2022). The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials. Journal of clinical medicine, vol. 11.
  25. Hahn, G. D., Golovics, P. A., Wetwittayakhlang, P., Al Khoury, A., Bessissow, T. & Lakatos, P. L. (2022). Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?. Biomedicines, vol. 10.

McGill

  1. Markarian, N. M., Galli, G., Patel, D., Hemmings, M., Nagpal, P., Berghuis, A. M., Abrahamyan, L. & Vidal, S. M. (2022). Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency. Frontiers in microbiology, vol. 13, p. 933983.
  2. Mancini, M. & Vidal, S. M. (2020). Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation. Annual review of immunology, vol. 38, p. 511-539.
  3. Mancini, M. & Vidal, S. M. (2018). Insights into the pathogenesis of herpes simplex encephalitis from mouse models. Mammalian genome : official journal of the International Mammalian Genome Society, vol. 29, p. 425-445.
  4. Kang, E., Crouse, A., Chevallier, L., Pontier, S. M., Alzahrani, A., Silué, N., Campbell-Valois, F.-X., Montagutelli, X., Gruenheid, S. & Malo, D. (2018). Enterobacteria and host resistance to infection. Mammalian genome : official journal of the International Mammalian Genome Society, vol. 29, p. 558-576.